Science reporter Education: Amherst College, BA in Physics and English; MIT, MS in Science Writing Carolyn Johnson is a science reporter. She previously covered the business of health, the pharmaceutical industry and the affordability of health care to consumers. Before coming to the Post, she covered science at the Boston Globe. Honors & Awards:
Finalist for the 2013 Pulitzer Prize in national reporting, as part of a team
The confident depiction by politicians and companies that a vaccine is imminent and inevitable may give people unrealistic beliefs about how soon the world can return to normal — and even spark resistance to simple strategies that can tamp down transmission.
Blood plasma from people who have successfully recovered from coronavirus infection has been widely used in the United States, even though researchers are still gathering evidence to definitively show it works.
Phase three trials of coronavirus vaccines are underway, as long as scientists can find 30,000 volunteers. How white moms on the front line of Portland protests are trying to balance power with privilege. Plus, a seismic quiet on Earth.
The unprecedented scientific quest to end the pandemic with a vaccine faces one of its most crucial tests, and nothing less than the success of the entire endeavor is at stake. A vaccine must work for everyone — young and old; black, brown and white.